The cobas test is based on allele‐specific real‐time PCR, and the detection limit has been reported to be 0.025%−0.15% by analysis using fragmented DNA isolated from lung cancer cell lines bearing EGFR mutations. The gene discussed is EGFR; the disease is lung carcinoma.